Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

OPK

Opko Health Inc

Feb 04 • 04:00PM ET

1.56

Dollar change +0.06
Percentage change 4.00	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: LH DGX MYGN EXAS MEDP CMRX VNDA BCRX TECH CRL

| Held by: IWM VTI VB VXF IWN VBR IBB VBK SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.19	Insider Own	54.79%	Shs Outstand	682.48M	Perf Week	4.00%
Market Cap	1.06B	Forward P/E	-	EPS next Y	-0.29	Insider Trans	0.54%	Shs Float	308.53M	Perf Month	7.59%
Income	-133.76M	PEG	-	EPS next Q	-0.09	Inst Own	30.00%	Short Float	28.50%	Perf Quarter	3.31%
Sales	711.40M	P/S	1.50	EPS this Y	28.00%	Inst Trans	3.04%	Short Ratio	22.32	Perf Half Y	15.56%
Book/sh	2.06	P/B	0.76	EPS next Y	-62.96%	ROA	-6.20%	Short Interest	87.92M	Perf Year	54.46%
Cash/sh	0.60	P/C	2.62	EPS next 5Y	20.98%	ROE	-9.39%	52W Range	0.86 - 1.76	Perf YTD	6.12%
Dividend Est.	-	P/FCF	-	EPS past 5Y	1.56%	ROI	-7.09%	52W High	-11.36%	Beta	1.74
Dividend TTM	-	Quick Ratio	2.69	Sales past 5Y	6.34%	Gross Margin	13.32%	52W Low	81.37%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	2.97	EPS Y/Y TTM	33.72%	Oper. Margin	-43.51%	RSI (14)	59.41	Volatility	3.48% 3.52%
Employees	3930	Debt/Eq	0.37	Sales Y/Y TTM	-17.95%	Profit Margin	-18.80%	Recom	1.00	Target Price	3.96
Option/Short	Yes / Yes	LT Debt/Eq	0.35	EPS Q/Q	122.15%	Payout	-	Rel Volume	1.48	Prev Close	1.50
Sales Surprise	-4.37%	EPS Surprise	132.15%	Sales Q/Q	-2.78%	Earnings	Nov 07 AMC	Avg Volume	3.94M	Price	1.56
SMA20	4.59%	SMA50	2.13%	SMA200	7.49%	Trades		Volume	5,827,561	Change	4.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-29-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$2
Dec-15-22	Initiated	H.C. Wainwright	Buy	$3
Jan-24-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Jun-21-21	Initiated	Ladenburg Thalmann	Buy	$7
Nov-25-19	Initiated	Piper Jaffray	Overweight	$2.50
Mar-02-18	Downgrade	JP Morgan	Neutral → Underweight
Sep-14-17	Downgrade	JP Morgan	Overweight → Neutral
Jun-21-16	Reiterated	Standpoint Research	Buy	$16 → $18
Jun-03-16	Initiated	Standpoint Research	Buy	$16
Mar-31-16	Reiterated	Barrington Research	Outperform	$17 → $16
Oct-16-15	Initiated	JP Morgan	Overweight	$14
Sep-11-15	Downgrade	Jefferies	Buy → Hold
Mar-03-15	Downgrade	Oppenheimer	Outperform → Perform
May-12-14	Reiterated	Oppenheimer	Outperform	$13 → $12
Mar-14-14	Initiated	Oppenheimer	Outperform	$13
Nov-13-13	Reiterated	Ladenburg Thalmann	Buy	$10 → $14.50
May-30-13	Reiterated	Ladenburg Thalmann	Buy	$8.50 → $10
Oct-22-12	Initiated	Barrington Research	Outperform	$6
Dec-01-11	Reiterated	Ladenburg Thalmann	Buy	$6 → $8.50
Jul-14-11	Initiated	Ladenburg Thalmann	Buy	$6

Show Previous Ratings

Jan-27-25 08:00AM	Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-20-25 10:02PM	OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential (Insider Monkey)
Jan-09-25 11:45AM	OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-07-25 08:00AM	OPKO Health's ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck (GlobeNewswire)
Dec-11-24 02:08AM	Is OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now? (Insider Monkey)
08:00AM	Loading…
Dec-10-24 08:00AM	NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer (PR Newswire)
Nov-29-24 02:43PM	Sleep Number, Getty Images, and More Stocks See Action From Activist Investors (Barrons.com)
Nov-20-24 08:00AM	OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-18-24 08:00AM	NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo (PR Newswire)
Nov-15-24 08:34PM	Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors (Barrons.com)
Nov-14-24 06:00AM	NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results (PR Newswire)
Nov-08-24 04:05PM	Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates (GlobeNewswire)
04:01AM	OPKO Health Inc (OPK) Q3 2024 Earnings Call Highlights: A Turnaround in Profitability Amidst ... (GuruFocus.com)
Nov-07-24 10:15PM	Opko Health (OPK) Q3 2024 Earnings Call Transcript (Motley Fool)
08:00PM	Here's What Key Metrics Tell Us About OPKO Health (OPK) Q3 Earnings (Zacks)
06:40PM	Loading…
06:40PM	OPKO Health (OPK) Q3 Earnings Surpass Estimates (Zacks)
05:35PM	OPKO Health: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results (GlobeNewswire)
08:00AM	Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference to Include OvaWatch (GlobeNewswire)
Oct-29-24 04:05PM	OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire) +6.67% -5.00%
Oct-07-24 08:00AM	NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan (PR Newswire)
08:00AM	ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program (GlobeNewswire)
Sep-25-24 08:30AM	Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders (GlobeNewswire)
Sep-23-24 08:00AM	OPKO Health's ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development (GlobeNewswire)
Sep-16-24 07:30AM	Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health (PR Newswire)
Aug-09-24 04:05PM	Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-08-24 12:14PM	OPKO Health (OPK) Q2 Earnings Top Estimates, Gross Margin Down (Zacks) +11.72%
12:15AM	Opko Health (OPK) Q2 2024 Earnings Call Transcript (Motley Fool)
Aug-07-24 08:00PM	OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:59PM	OPKO Health: Q2 Earnings Snapshot (Associated Press Finance)
04:06PM	Loading…
04:06PM	OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results (GlobeNewswire)
Aug-01-24 04:05PM	OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024 (GlobeNewswire)
Jul-18-24 08:00AM	OPKO Health Announces $100 Million Share Repurchase Program (GlobeNewswire) +7.04%
Jul-17-24 04:14PM	OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments (GlobeNewswire)
Jul-08-24 06:54PM	OPKO Health, Inc. (OPK): Most Shorted Stock Loved by Analysts Right Now? (Insider Monkey)
12:30PM	10 Most Shorted Stocks That Are Loved by Analysts (Insider Monkey)
Jul-02-24 08:00AM	NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner (PR Newswire)
Jun-06-24 11:31AM	Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report? (Zacks)
May-31-24 10:48AM	OPKO Health to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
10:00AM	The 2024 Millionaire's Club: 3 Penny Stocks to Buy Now (InvestorPlace)
May-12-24 03:24PM	5 Penny Stocks with Insider Buying in 2024 (Insider Monkey)
May-09-24 09:18AM	OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y (Zacks)
May-08-24 11:47AM	OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript (Insider Monkey)
06:56AM	Q1 2024 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
03:44AM	OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ... (GuruFocus.com)
May-07-24 09:15PM	Opko Health (OPK) Q1 2024 Earnings Call Transcript (Motley Fool)
08:30PM	OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:09PM	OPKO Health Inc (OPK) Q1 2024 Earnings: Misses Revenue and Earnings Estimates (GuruFocus.com)
05:30PM	OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:38PM	OPKO Health: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results (GlobeNewswire)
May-03-24 08:00AM	OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 (GlobeNewswire)
Apr-01-24 01:01PM	OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp (Zacks) +9.17%
Mar-28-24 11:08PM	Labcorp inks $237.5M buyout of Opkos reproductive, womens health testing assets (MedTech Dive) +12.15%
08:00AM	Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business (PR Newswire)
Mar-25-24 09:57AM	OPKO Health (OPK) And Entera Bio Announce Data for GLP-2 (Zacks)
Mar-20-24 08:00AM	Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome (GlobeNewswire)
Mar-05-24 08:52AM	AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV (GlobeNewswire) -6.51%
Feb-29-24 08:31AM	OPKO Health, Inc. (NASDAQ:OPK) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 09:31AM	NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st (PR Newswire) -6.14%
09:02AM	OPKO Health's (OPK) Q4 Earnings Match Estimates, Revenues Top (Zacks)
06:18AM	Q4 2023 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-27-24 09:00PM	Opko Health (OPK) Q4 2023 Earnings Call Transcript (Motley Fool) +5.37%
07:30PM	OPKO Health (OPK) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
06:10PM	OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:08PM	OPKO Health: Q4 Earnings Snapshot (Associated Press Finance)
04:43PM	OPKO Health Inc (OPK) Reports Fourth Quarter 2023 Results (GuruFocus.com)
04:05PM	OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results (GlobeNewswire)
Feb-26-24 09:16AM	Gear Up for OPKO Health (OPK) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks) +5.34%
Feb-22-24 04:05PM	OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024 (GlobeNewswire)
Feb-08-24 01:48PM	Hedge Fund and Insider Trading News: Adam Schwartz, Bill Ackman, Eisler Capital, Brevan Howard Asset Management, Balyasny Asset Management, Citadel LLC, OPKO Health, Inc. (OPK), and More (Insider Monkey)
Feb-05-24 08:09AM	NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China (PR Newswire)
Jan-22-24 11:48AM	3 Stocks with Major Insider Buying This Month (InvestorPlace)
Jan-09-24 04:05PM	OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes (GlobeNewswire)
Jan-08-24 08:00AM	OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +12.54%
Jan-04-24 11:31PM	OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 (GlobeNewswire) -39.55%
Jan-03-24 05:05PM	OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029 (GlobeNewswire)
Dec-07-23 10:20AM	Here's Why You Should Retain OPKO Health (OPK) Stock for Now (Zacks)
Dec-06-23 11:30AM	Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report? (Zacks)
Nov-28-23 07:00AM	BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing (PR Newswire)
Nov-07-23 10:36AM	Q3 2023 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
10:29AM	OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top (Zacks)
09:19AM	OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript (Insider Monkey)
06:45AM	BioReference Signs On as the First Laboratory to Use MSK-ACCESS Powered with SOPHiA DDM (PR Newswire)
01:00AM	Opko Health (OPK) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-06-23 07:30PM	OPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:30PM	OPKO Health: Q3 Earnings Snapshot (Associated Press Finance)
05:01PM	OPKO Health Inc (OPK) Reports Third Quarter 2023 Financial Results (GuruFocus.com)
04:05PM	OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results (GlobeNewswire)
Nov-02-23 10:00AM	New Clinical Data on OPKO Health's RAYALDEE (ER Calcifediol) Presented at Kidney Week 2023 (GlobeNewswire)
Oct-31-23 08:00AM	OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023 (GlobeNewswire)
Oct-25-23 04:25PM	OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023 (GlobeNewswire)
Oct-12-23 10:50AM	NextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global (ACCESSWIRE)
Oct-06-23 12:03PM	OPKO Health (OPK) Gets BARDA Contract to Combat Antibody Threats (Zacks)
Sep-29-23 01:03PM	OPKO Health Inc (OPK): A Deep Dive into Its Performance Potential (GuruFocus.com) +6.67%
Sep-28-23 07:36PM	OPKO Health (OPK) - A Fairly Valued Stock with Room for Growth? (GuruFocus.com)
04:08PM	ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats (GlobeNewswire)
Sep-13-23 01:18PM	OPKO Health (OPK) Ties Up for Oral Peptide Tablet Formulations (Zacks)
Sep-12-23 08:30AM	Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes (GlobeNewswire)
Aug-28-23 11:56AM	Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio (Zacks)

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FROST PHILLIP MD ET AL	CEO & Chairman	Jan 28 '25	Buy	1.47	47,537	70,060	213,234,014	Jan 28 05:40 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Jan 17 '25	Buy	1.47	150,000	220,425	213,186,477	Jan 17 05:06 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Jan 15 '25	Buy	1.48	500,000	740,850	213,036,477	Jan 15 05:18 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Dec 13 '24	Buy	1.59	125,000	199,375	212,536,477	Dec 13 05:04 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Dec 11 '24	Buy	1.56	500,000	781,050	212,411,477	Dec 11 05:21 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Nov 29 '24	Buy	1.53	199,072	305,376	211,911,477	Nov 29 03:20 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Nov 22 '24	Buy	1.59	100,000	159,000	211,712,405	Nov 22 05:17 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Nov 14 '24	Buy	1.62	100,000	161,980	211,612,405	Nov 14 05:51 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Nov 08 '24	Buy	1.50	280,183	421,535	211,512,405	Nov 08 05:40 PM
OPKO HEALTH, INC.	10% Owner	Sep 17 '24	Proposed Sale	40.88	13,404	547,956		Sep 20 02:56 PM
OPKO HEALTH, INC.	10% Owner	Aug 19 '24	Sale	34.49	50,000	1,724,520	2,646,972	Aug 19 05:23 PM
OPKO HEALTH, INC.	10% Owner	Aug 16 '24	Sale	34.30	50,000	1,714,850	2,696,972	Aug 19 05:23 PM
OPKO HEALTH, INC.	10% Owner	Aug 15 '24	Sale	33.08	39,824	1,317,505	2,746,972	Aug 19 05:23 PM
OPKO HEALTH, INC.	10% Owner	Aug 12 '24	Sale	33.95	59,787	2,029,811	2,811,783	Aug 14 04:50 PM
OPKO HEALTH, INC.	10% Owner	Aug 13 '24	Sale	34.76	24,987	868,503	2,786,796	Aug 14 04:50 PM
OPKO HEALTH, INC.	10% Owner	Aug 08 '24	Sale	31.82	100,000	3,182,380	2,871,570	Aug 08 05:39 PM
OPKO HEALTH, INC.	10% Owner	Aug 06 '24	Sale	29.35	12,994	381,427	2,971,570	Aug 08 05:39 PM
OPKO HEALTH, INC.	10% Owner	Jul 31 '24	Sale	33.50	88,839	2,976,346	2,984,564	Aug 02 04:21 PM
OPKO HEALTH, INC.	10% Owner	Jul 29 '24	Sale	33.86	50,000	1,692,890	3,073,403	Jul 31 05:03 PM
OPKO HEALTH, INC.	10% Owner	Jul 24 '24	Sale	33.72	75,000	2,529,105	3,183,403	Jul 26 07:49 PM
OPKO HEALTH, INC.	10% Owner	Jul 26 '24	Sale	33.85	60,000	2,031,258	3,123,403	Jul 26 07:49 PM
OPKO HEALTH, INC.	10% Owner	Jul 23 '24	Sale	33.46	75,000	2,509,245	3,258,403	Jul 23 05:16 PM
OPKO HEALTH, INC.	10% Owner	Jul 22 '24	Sale	32.61	50,000	1,630,440	3,333,403	Jul 23 05:16 PM
OPKO HEALTH, INC.	10% Owner	Jul 19 '24	Sale	32.29	25,000	807,250	3,383,403	Jul 23 05:16 PM
OPKO HEALTH, INC.	10% Owner	Jul 17 '24	Sale	32.93	25,000	823,188	3,408,403	Jul 19 06:46 PM
OPKO HEALTH, INC.	10% Owner	Jul 05 '24	Sale	28.24	36,118	1,020,016	3,433,403	Jul 09 04:07 PM
OPKO HEALTH, INC.	10% Owner	Jul 01 '24	Sale	26.63	50,000	1,331,700	3,508,603	Jul 03 04:56 PM
OPKO HEALTH, INC.	10% Owner	Jul 02 '24	Sale	29.12	25,000	728,095	3,483,603	Jul 03 04:56 PM
OPKO HEALTH, INC.	10% Owner	Jul 03 '24	Sale	28.23	14,082	397,491	3,469,521	Jul 03 04:56 PM
FROST PHILLIP MD ET AL	CEO & Chairman	May 23 '24	Buy	1.27	100,000	126,937	211,232,222	May 23 08:04 PM
FROST PHILLIP MD ET AL	CEO & Chairman	May 17 '24	Buy	1.29	163,997	211,195	211,132,222	May 17 05:31 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Mar 18 '24	Buy	0.87	500,000	437,100	210,968,225	Mar 18 04:45 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Mar 14 '24	Buy	0.89	500,000	444,300	210,468,225	Mar 14 05:00 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Mar 13 '24	Buy	0.93	500,000	463,750	209,968,225	Mar 13 04:44 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Mar 12 '24	Buy	0.93	600,000	559,380	209,468,225	Mar 12 05:27 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Feb 28 '24	Buy	0.99	500,000	496,150	208,868,225	Feb 28 05:31 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Feb 21 '24	Buy	0.99	1,000,000	991,700	208,368,225	Feb 21 05:10 PM
FROST PHILLIP MD ET AL	CEO & Chairman	Feb 07 '24	Buy	0.98	1,500,000	1,462,800	207,368,225	Feb 07 05:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OPK

Opko Health Inc

Upgrade your FINVIZ experience